• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

TAR-200 Achieves High DFS and Bladder Preservation Rates in Bladder Cancer Subgroups

by MM360 Staff | Apr 28, 2025 | Uncategorized

Source: CureToday articles TAR-200 demonstrated a high disease-free survival and bladder preservation rates in BCG-unresponsive, high-risk non-muscle-invasive bladder cancer. Read More

Zongertinib Elicits Responses in HER2-Mutant NSCLC

by MM360 Staff | Apr 28, 2025 | Uncategorized

Source: CureToday articles Zongertinib elicited meaningful results in previously treated patients with HER2-mutated, advanced non–small cell lung cancer. Read More

How an Advocate Unites Voices to Guide MPN Research Decisions

by MM360 Staff | Apr 28, 2025 | Uncategorized

Source: CureToday articles Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population. Read More

Treatment With HT-KIT Shows Early Preclinical Activity in GIST Models

by MM360 Staff | Apr 27, 2025 | Uncategorized

Source: CureToday articles HT-KIT, a novel targeted therapy for GIST, demonstrated the ability to reduce tumor burden in humanized mouse models and induce tumor cell death. Read More

Healer, Mentor and Leader

by MM360 Staff | Apr 27, 2025 | Uncategorized

Source: CureToday articles Reflecting upon my relationship with Jill over the past 25 years, I am in awe of all she has accomplished. Read More

FDA OKs Investigational New Drug Application for VS-7375 in Solid Tumors

by MM360 Staff | Apr 26, 2025 | Uncategorized

Source: CureToday articles Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be presented at ASCO 2025. Read More
« Older Entries
Next Entries »

Recent Content

  • Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from Clinical Trials
  • Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study
  • Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma
  • Subcutaneous Darzalex Faspro Extends PFS in Smoldering Myeloma
  • A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients
  • Subcutaneous Bortezomib Associated With Reduced Incidence of Peripheral Neuropathy in Multiple Myeloma
  • Multiple Myeloma: Key Insights on Diagnosis and Evolving Treatment Strategies
  • Multiple myeloma associated long non-coding RNA PLUM confers chemoresistance by enhancing PRC2 mediated UPR pathway activation
  • Mobilization of hematopoietic stem cells using G-CSF with or without cyclophosphamide before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma receiving induction therapy with or without daratumumab
  • Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT